Metabolic syndrome and renal cell carcinoma

被引:0
作者
Gui-Ming Zhang
Yao Zhu
Ding-Wei Ye
机构
[1] Fudan University Shanghai Cancer Center,Department of Urology
[2] Shanghai Medical College,Department of Oncology
[3] Fudan University,undefined
来源
World Journal of Surgical Oncology | / 12卷
关键词
Metabolic syndrome; Renal cell carcinoma; Insulin resistance; Mechanism;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 683 条
[1]  
Ford ES(2010)Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US J Diabetes 2 180-193
[2]  
Li C(2007)Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with carotid intima-media thickness J Hypertens 25 2463-2470
[3]  
Zhao G(2009)Prevalence of the metabolic syndrome in Latin America and its association with sub-clinical carotid atherosclerosis: the CARMELA cross sectional study Cardiovasc Diabetol 8 52-257
[4]  
Zanchetti A(2005)The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population Diabetes Res Clin Pract 67 251-1607
[5]  
Hennig M(1988)Banting lecture 1988. Role of insulin resistance in human disease Diabetes 37 1595-228
[6]  
Baurecht H(2013)Metabolic syndrome and hepatocellular carcinoma risk Br J Cancer 108 222-301
[7]  
Tang R(2012)Metabolic syndrome components and risk factors for pancreatic adenocarcinoma: a case–control study in China Digestion 86 294-116
[8]  
Cuspidi C(2013)Prospective cohort study of metabolic risk factors and gastric adenocarcinoma risk in the Metabolic Syndrome and Cancer Project (Me-Can) Cancer Causes Control 24 107-5002
[9]  
Carugo S(2012)Metabolic syndrome and colorectal cancer: a cross-sectional survey Asian Pac J Cancer Prev 13 4999-1898
[10]  
Mancia G(2011)Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can) Int J Cancer 128 1890-494